![Yvonne McGrath](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yvonne McGrath
Directeur Technique/Scientifique/R&D chez
ITEOS THERAPEUTICS, INC.
Profil
Yvonne McGrath currently works at iTeos Therapeutics, Inc., as Chief Scientific Officer from 2022.
Dr. McGrath also formerly worked at Complix NV, as Director & Chief Scientific Officer from 2014 to 2020, Immunocore Holdings Plc, as Head-Development from 2010 to 2014, and Immunocore Ltd., as Head-Development from 2010 to 2014.
Dr. McGrath received her undergraduate degree from Queen’S University Belfast and doctorate degree from Cardiff University School of Medicine.
Postes actifs de Yvonne McGrath
| Sociétés | Poste | Début |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/05/2020 |
Anciens postes connus de Yvonne McGrath
| Sociétés | Poste | Fin |
|---|---|---|
Complix NV
 Complix NV Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical | Directeur Technique/Scientifique/R&D | 01/04/2020 |
| IMMUNOCORE HOLDINGS PLC | Corporate Officer/Principal | 01/04/2014 |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Corporate Officer/Principal | 01/04/2014 |
Formation de Yvonne McGrath
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Complix NV
Complix NV Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical | Health Technology |
Cardiff University School of Medicine
 Cardiff University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Queen’S University Belfast
 Queen’S University Belfast Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
